诊断学理论与实践 ›› 2019, Vol. 18 ›› Issue (04): 377-382.doi: 10.16150/j.1671-2870.2019.04.001
• 专家论坛 • 下一篇
陈平, 吴云林
收稿日期:2019-07-09
出版日期:2019-08-25
发布日期:2019-08-25
基金资助:
Received:2019-07-09
Online:2019-08-25
Published:2019-08-25
中图分类号:
陈平, 吴云林. 胃癌、结肠直肠癌血清标志物在疾病筛查、诊断中的应用新进展[J]. 诊断学理论与实践, 2019, 18(04): 377-382.
| [1] |
Suenaga Y, Kanda M, Ito S, et al. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer[J]. World J Gastrointest Oncol, 2019, 11(1):17-27.
doi: 10.4251/wjgo.v11.i1.17 URL |
| [2] | Jia J, Zhang P, Gou M, et al. The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer[J]. Dis Markers, 2019, 2019:6812045. |
| [3] | Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death[J]. Aust Med J, 1869, 14:146. |
| [4] |
Arigami T, Uenosono Y, Yanagita S, et al. Clinical significance of circulating tumor cells in blood from patients with gastric cancer[J]. Ann Gastroenterol Surg, 2017, 1(1):60-68.
doi: 10.1002/ags3.12005 URL |
| [5] |
Liu JL, Gao W, Kang QM, et al. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis[J]. PLoS One, 2013, 8(8):e71930.
doi: 10.1371/journal.pone.0071930 URL |
| [6] |
Yie SM, Lou B, Ye SR, et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse[J]. Ann Surg Oncol, 2008, 15(11):3073-3082.
doi: 10.1245/s10434-008-0069-x URL |
| [7] |
Bertazza L, Mocellin S, Marchet A, et al. Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival[J]. J Transl Med, 2009, 7:111.
doi: 10.1186/1479-5876-7-111 pmid: 20028510 |
| [8] |
Arigami T, Uenosono Y, Hirata M, et al. Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis[J]. J Surg Oncol, 2010, 102(7):748-752.
doi: 10.1002/jso.21722 URL |
| [9] |
Huang MY, Tsai HL, Huang JJ, et al. Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer[J]. Transl Oncol, 2016, 9(4):340-347.
doi: 10.1016/j.tranon.2016.06.006 URL |
| [10] |
Yamamoto S, Shimizu K, Fei J, et al. Ex vivo culture of circulating tumor cells using magnetic force-based coculture on a fibroblast feeder layer[J]. Biotechnol J, 2016, 11(11):1433-1442.
doi: 10.1002/biot.201600084 pmid: 27731546 |
| [11] |
Emami SS, Nekouian R, Akbari A, et al. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer[J]. J Cancer Res Ther, 2019, 15(1):115-119.
doi: 10.4103/jcrt.JCRT_1020_16 URL |
| [12] |
Necula L, Matei L, Dragu D, et al. Recent advances in gastric cancer early diagnosis[J]. World J Gastroenterol, 2019, 25(17):2029-2044.
doi: 10.3748/wjg.v25.i17.2029 URL |
| [13] |
Roh MS, Lee HW, Jung SB, et al. Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer[J]. Pathol Res Pract, 2018, 214(3):350-355.
doi: 10.1016/j.prp.2018.01.005 URL |
| [14] |
Wu Y, Song Y, Xiong Y, et al. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer[J]. Cell Physiol Biochem, 2017, 43(3):945-958.
doi: 10.1159/000481648 URL |
| [15] |
Fukushima Y, Iinuma H, Tsukamoto M, et al. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer[J]. Oncol Rep, 2015, 33(2):573-582.
doi: 10.3892/or.2014.3614 URL |
| [16] |
Hollis M, Nair K, Vyas A, et al. MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity[J]. World J Gastroenterol, 2015, 21(27):8284-8292.
doi: 10.3748/wjg.v21.i27.8284 URL |
| [17] |
Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules exis-ting as highly base-paired rod-like structures[J]. Proc Natl Acad Sci U S A, 1976, 73(11):3852-3856.
doi: 10.1073/pnas.73.11.3852 pmid: 1069269 |
| [18] |
Li P, Chen S, Chen H, et al. Using circular RNA as a novel type of biomarker in the screening of gastric cancer[J]. Clin Chim Acta, 2015, 444:132-136.
doi: 10.1016/j.cca.2015.02.018 URL |
| [19] |
Sun H, Tang W, Rong D, et al. Hsa_circ_0000520, a potential new circular RNA biomarker, is involved in gastric carcinoma[J]. Cancer Biomark, 2018 Feb 6; 21(2):299-306.
doi: 10.3233/CBM-170379 URL |
| [20] | Shi P, Wan J, Song H, et al. The emerging role of circular RNAs in gastric cancer[J]. Am J Cancer Res, 2018, 8(10):1919-1932. |
| [21] |
Lei B, Tian Z, Fan W, et al. Circular RNA: a novel biomarker and therapeutic target for human cancers[J]. Int J Med Sci, 2019, 16(2):292-301.
doi: 10.7150/ijms.28047 pmid: 30745810 |
| [22] |
Weng W, Wei Q, Toden S, et al. Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer[J]. Clin Cancer Res, 2017, 23(14):3918-3928.
doi: 10.1158/1078-0432.CCR-16-2541 URL |
| [23] |
Shahjehan F, Kamatham S, Kasi PM. Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018[J]. Front Oncol, 2019, 9:358.
doi: 10.3389/fonc.2019.00358 pmid: 31139561 |
| [24] |
Fang WL, Lan YT, Huang KH, et al. Clinical significance of circulating plasma DNA in gastric cancer[J]. Int J Cancer, 2016, 138(12):2974-2983.
doi: 10.1002/ijc.30018 URL |
| [25] |
Hu Y, Guo H, Chen Y, et al. The mutational landscape of circulating cell free DNA in patients with colorectal adenoma and carcinoma[J]. J Clin Oncol, 2018, 36(15_suppl):e15662.
doi: 10.1200/JCO.2018.36.15_suppl.e15662 URL |
| [26] |
Kim K, Shin DG, Park MK, et al. Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection[J]. Ann Surg Treat Res, 2014, 86(3):136-142.
doi: 10.4174/astr.2014.86.3.136 URL |
| [27] |
Kehagias P, Vandeputte C, Ameye L, et al. High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib[J]. J Clin Oncol, 2018, 36 (15_suppl):3532.
doi: 10.1200/JCO.2018.36.15_suppl.3532 URL |
| [28] |
Murray DH, Symonds EL, Young GP, et al. Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival[J]. J Cancer Res Clin Oncol, 2018, 144(9):1741-1750.
doi: 10.1007/s00432-018-2701-x pmid: 29992492 |
| [29] |
Sánchez-Zauco N, Torres J, Gómez A, et al. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study[J]. BMC Cancer, 2017, 17(1):384.
doi: 10.1186/s12885-017-3310-9 pmid: 28558708 |
| [30] |
Vainer N, Dehlendorff C, Johansen JS. Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer[J]. Oncotarget, 2018, 9(51):29820-29841.
doi: 10.18632/oncotarget.25661 pmid: 30038723 |
| [31] |
Hong JT, Son DJ, Lee CK, et al. Interleukin 32, inflammation and cancer[J]. Pharmacol Ther, 2017, 174:127-137.
doi: 10.1016/j.pharmthera.2017.02.025 URL |
| [32] |
Liu Y, Yao J. Research progress of cystatin SN in cancer[J]. Onco Targets Ther, 2019, 12:3411-3419.
doi: 10.2147/OTT.S194332 URL |
| [1] | 何亲羽, 王伟, 陈立芬, 张雪蕾, 董治亚. LHCGR基因突变致家族性男性性早熟2例报告及文献复习[J]. 诊断学理论与实践, 2022, 21(05): 598-605. |
| [2] | 武冬冬, 陈玉辉, 刘芳, 刘银红, 蒋景文. 脑小血管疾病合并中枢神经系统退行性疾病机制的研究进展[J]. 诊断学理论与实践, 2022, 21(05): 644-649. |
| [3] | 陈志敏, 何浩岚. 艾滋病合并马尔尼菲篮状菌病的诊治现状[J]. 诊断学理论与实践, 2022, 21(04): 425-430. |
| [4] | 沈银忠. 《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436. |
| [5] | 陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534. |
| [6] | 周思锋, 徐海舒, 范欣生. 基于不同生物样本代谢组学的OSAHS生物标志物研究进展[J]. 诊断学理论与实践, 2022, 21(04): 535-540. |
| [7] | 何新, 陈慧, 冯炜炜. 机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546. |
| [8] | 徐子真, 李擎天, 刘湘帆, 李莉, 李惠, 王也飞, 吴洁敏, 陈宁, 梁璆荔, 陈松立, 戴健敏, 宋珍, 丁磊. 实验诊断学在线课程的建立和实践[J]. 诊断学理论与实践, 2022, 21(04): 547-550. |
| [9] | 赵然, 詹维伟, 侯怡卿. 计算机辅助诊断系统辅助超声诊断甲状腺弥漫性病变合并结节良恶性的应用价值[J]. 诊断学理论与实践, 2022, 21(03): 390-394. |
| [10] | 阮玉凤, 胡丽萍, 陈史蓉, 尹君, 孙璟. 上海浦东新区全科医师对规范化诊治幽门螺杆菌感染掌握程度的调研[J]. 诊断学理论与实践, 2022, 21(03): 399-404. |
| [11] | 郭业兵, 郑金峰. 阴道壁胃肠道外间质瘤一例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(03): 405-407. |
| [12] | 王刚, 陈生弟. 神经病学的诊断：起源、发展及挑战[J]. 诊断学理论与实践, 2022, 21(01): 1-4. |
| [13] | 唐静仪, 余群, 刘军. 结合人工智能的结构影像分析对阿尔茨海默病的早期预测及精准诊断研究进展[J]. 诊断学理论与实践, 2022, 21(01): 12-17. |
| [14] | 李建平, 任汝静, 王刚. 阿尔茨海默病的临床诊治进展[J]. 诊断学理论与实践, 2022, 21(01): 18-21. |
| [15] | 魏文石. 直面我国阿尔茨海默病诊治的挑战——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 5-7. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
